INTERMOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intermolecular, Inc. – IMI
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the
law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the
proposed sale of Intermolecular, Inc. (NasdaqGS: IMI) to a wholly owned
subsidiary of Merck KGaA, Darmstadt, Germany. Under the terms of the
proposed transaction, shareholders of Intermolecular will receive only
$1.20 in cash for each share of Intermolecular that they own. KSF is
seeking to determine whether this consideration and the process that led
to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if
you would like to discuss your legal rights regarding the proposed sale,
you may, without obligation or cost to you, e-mail or call KSF Managing
Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com)
toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-imi/
to learn more.
To learn more about KSF, whose partners include the Former Louisiana
Attorney General, visit www.ksfcounsel.com.
Contacts
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850